Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TeaLief Brand was a U.S. cannabis wellness brand focused on commercially selling organic cannabidiol-infused tea products rather than developing regulated biopharmaceutical therapeutics. Its product line included CBD tea bags in caffeinated and non-caffeinated varieties and it operated as a consumer packaged goods brand in the hemp/CBD space. TeaLief Brand was acquired by NewLeaf Brands in 2019 as part of NewLeaf’s portfolio build-out of CBD lifestyle subsidiaries. Based on the available evidence, TeaLief Brand does not appear to be a biotech, pharma, or healthcare services company in the conventional life sciences sense, but rather a cannabis-derived wellness products company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TeaLief Brand.